MRKR is Marker Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.18. Market cap: $20M. Capital Quality Rank: 2/100 — Systemic risk.
Stock snapshot
| Price | $1.18 |
| Market cap | $20M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 2 / 100 · Systemic risk |
| ROIC (TTM) | -1397.3% |
| Revenue CAGR (3y) | 0.3% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Distress |
About MRKR
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).
Related non-dividend companies
Other non-dividend stocks investors research alongside MRKR. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is MRKR's current stock price?
MRKR (Marker Therapeutics, Inc.) is currently trading at $1.18.
Does MRKR pay a dividend?
MRKR (Marker Therapeutics, Inc.) does not currently pay a regular dividend.
What is MRKR's Capital Quality Rank?
MRKR has a Capital Quality Rank of 2/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track MRKR in DiviDrip
Add MRKR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search MRKR and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.